Dirk Hoffmann
Impact in
- Geriatrics and Gerontology top 10%
- Virology top 10%
- HIV Research and Treatment
Papers in
- Genetics 14
- Virus-based gene therapy research 10
-
- CRISPR and Genetic Engineering 13
- RNA Interference and Gene Delivery 9
- Pluripotent Stem Cells Research 6
- Advanced biosensing and bioanalysis techniques 3
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Axel Schambach (25 shared papers)Thomas E. Moritz (5 shared papers)Nico Lachmann (5 shared papers)Doris Steinemann (8 shared papers)Mania Ackermann (3 shared papers)Joachim Hauber (2 shared papers)Carina Banning (2 shared papers)Michael Alexander Morgan (8 shared papers)
- Journals
- Stem Cell Reports (4 papers)Gene Therapy (3 papers)Human Gene Therapy (3 papers)Molecular Therapy (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Dirk Hoffmann
31 papers receiving 990 citations
Peers
Comparison fields: 5 of 98
- Geriatrics and Gerontology 36
- Virology 49
- Immunology 194
- Genetics 227
- Molecular Biology 556
Countries citing papers authored by Dirk Hoffmann
This map shows the geographic impact of Dirk Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hoffmann more than expected).
Fields of papers citing papers by Dirk Hoffmann
This network shows the impact of papers produced by Dirk Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hoffmann. The network helps show where Dirk Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 177 | |
| 2 | 2010 | 133 | |
| 3 | 2011 | 66 | |
| 4 | 2018 | 62 | |
| 5 | 2015 | 62 | |
| 6 | 2017 | 45 | |
| 7 | 2016 | 44 | |
| 8 | 2019 | 41 | |
| 9 | 2013 | 34 | |
| 10 | 2019 | 34 | |
| 11 | 2006 | 31 | |
| 12 | 2019 | 28 | |
| 13 | 2019 | 27 | |
| 14 | 2012 | 21 | |
| 15 | 2016 | 21 | |
| 16 | 2014 | 21 | |
| 17 | 2022 | 17 | |
| 18 | 2018 | 17 | |
| 19 | 2017 | 17 | |
| 20 | 2020 | 15 |
About Dirk Hoffmann
Dirk Hoffmann is a scholar working on Genetics, Molecular Biology, Immunology, Hematology and Oncology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (9 papers), Pluripotent Stem Cells Research (6 papers), CAR-T cell therapy research (3 papers), Acute Myeloid Leukemia Research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (36 citations), Virology (49 citations), Immunology (194 citations), Genetics (227 citations) and Molecular Biology (556 citations). Dirk Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Axel Schambach, Thomas E. Moritz, Nico Lachmann, Doris Steinemann, Mania Ackermann, Joachim Hauber, Carina Banning, Michael Alexander Morgan, Michael Schindler and Rudolph Reimer. Their work appears in journals such as Stem Cell Reports, Gene Therapy, Human Gene Therapy, Molecular Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.